Z Gastroenterol 2004; 42 - 128
DOI: 10.1055/s-2004-827029

Peutz-Jeghers syndrome: Clinical characteristics, risk of malignancies and importance of surveillance

P Sarlós 1, Á Király 1, L Nagy 1
  • 13rd Dept. of Medicine, University of Pécs Medical Centre, Pécs

Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant hereditary disease characterized by mucocutaneous pigmentation, gastrointestinal hamartomatous polyposis and an increased risk for the development of gastrointestinal and extragastrointestinal malignancies.

Aim and methods: Five generations of two PJS families (21–21 patients) were analyzed to summarize the clinical appearance of the disorder by interview, physical examination, laboratory and imaging studies.

Results: Phenotypic variability was observed in PJS both in and between families. In family “A” 13 people were diagnosed as being affected, all of them had melanin spots at birth and the first presenting clinical symptom was colic abdominal pain (median age 12, range: 2–35) resulting in 14 laparotomies in 9 of the affected persons. 4/13 patients died from small-bowel ileus (median age 7, range 2–31 years), 2/13 from cancer occurred in the GI tract (median age 54 years). In family “B” 7 patients were documented as being affected. The first features were also abdominal cramps (at age 22). The main causes of death were gynaecological (1/5) and GI malignancies (4/5) at advanced age, no one died in ileus.

Conclusions: The results based on the analysis of the two families suggest that PJS is not a benign disease. It is difficult to predict the outcome of the disorder regarding the variable expression and incomplete penetrance. Therefore we emphasize the importance of checking the pedigree, finding out the leading symptom in the family, haemocult test and routine lab studies should be carried out at every affected individual. If clinical signs and symptoms are present we recommend to perform the complete diagnostic protocol and a yearly follow-up by a gastroenterologist familiar with PJS focusing on the leading symptoms.